(Q45954513)

18 December 2017

title

Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study. (English)

1 reference

18 December 2017

author

Philip Savage

5

1 reference

18 December 2017

Neil J. Sebire

6

1 reference

18 December 2017

author name string

Peter Schmid

1

1 reference

18 December 2017

Yutaka Nagai

2

1 reference

18 December 2017

Roshan Agarwal

3

1 reference

18 December 2017

Barry Hancock

4

1 reference

18 December 2017

Iain Lindsay

7

1 reference

18 December 2017

Michael Wells

8

1 reference

18 December 2017

Rosemary A Fisher

9

1 reference

18 December 2017

Delia Short

10

1 reference

18 December 2017

Edward S Newlands

11

1 reference

18 December 2017

Manfred B Wischnewsky

12

1 reference

18 December 2017

Michael J Seckl

13

1 reference

18 December 2017

language of work or name

English

0 references

publication date

22 June 2009

1 reference

18 December 2017

published in

The Lancet

1 reference

18 December 2017

volume

374

1 reference

18 December 2017

issue

9683

1 reference

18 December 2017

page(s)

48-55

1 reference

18 December 2017

Trophoblastic pseudotumor of the uterus.An exaggerated form of “syncytial endometritis” simulating a malignant tumor

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960618-8

7 January 2021

Trophoblastic pseudotumor—Evidence of malignant disease potential

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960618-8

7 January 2021

Placental site trophoblastic tumour (trophoblastic pseudotumour): a study of four cases requiring hysterectomy including one fatal case

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960618-8

7 January 2021

Trophoblastic pseudotumor: a reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960618-8

7 January 2021

Placental site trophoblastic tumor: A study of 55 cases and review of the literature emphasizing factors of prognostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960618-8

7 January 2021

Placental site trophoblastic tumour: clinical features and management.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960618-8

7 January 2021

Genetic evidence that placental site trophoblastic tumours can originate from a hydatidiform mole or a normal conceptus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960618-8

7 January 2021

Placental site trophoblastic tumour arising from a partial hydatidiform mole

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960618-8

7 January 2021

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960618-8

7 January 2021

FIGO staging for gestational trophoblastic neoplasia 2000. FIGO Oncology Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960618-8

7 January 2021

EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960618-8

7 January 2021

Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastati

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960618-8

7 January 2021

Residual lung lesions after completion of chemotherapy for gestational trophoblastic neoplasia: should we operate?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960618-8

7 January 2021

Placental site trophoblastic tumor: outcome of five cases including fertility preserving management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960618-8

7 January 2021

Case of PSTT treated with chemotherapy followed by open uterine tumor resection to preserve fertility

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960618-8

7 January 2021

Treatment of placental site trophoblastic tumor with hysterotomy and uterine reconstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960618-8

7 January 2021

Fertility-sparing partial hysterectomy for placental-site trophoblastic tumour

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960618-8

7 January 2021

Current management of gestational trophoblastic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960618-8

7 January 2021

Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960618-8

7 January 2021

Placental site trophoblastic tumor: a 17-year experience at the New England Trophoblastic Disease Center

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960618-8

7 January 2021

Prognostic factors and treatment for placental site trophoblastic tumor-report of 3 cases and analysis of 88 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960618-8

7 January 2021

10.1016/S0140-6736(09)60618-8

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017